Phase 2 Study of ITCA 650 in Subjects With Type 2 Diabetes Mellitus
Phase 2 Study of ITCA 650 in Subjects With Type 2 Diabetes Mellitus
The purpose of this study is to determine safety, efficacy and tolerability of various doses of ITCA 650 in subjects with type 2 diabetes.
Inclusion Criteria:
Exclusion Criteria: